/ /

LATEST

Marketing your practice on social media platformsSuccessful online marketing requires a multifaceted approach to social media. Use multiple platforms to reach your audience in different ways, with the intent to educate and reach patients.
The secret to reducing staff turnoverIs staff turnover holding you back? In some markets, healthcare personnel turnover is five times higher than unemployment. The average total turnover rate reported for healthcare employers in 2016 is 20.1%, up from 19.2% in 2015, according to Compdata Surveys’ national survey, Compensation Data Healthcare.
Case of profound posterior pressureWhile participating in an ORBIS Flying Eye Hospital program in Trujillo, Peru, and operating on an elderly patient with a dense cataract under peribulbar anesthesia, James Lehmann, MD, encountered iris prolapse as soon as he made the paracentesis.
Micro-instrumentation reduces trauma in IOL exchangeIncreased procedure volume and patient expectations have made IOL exchange procedures more common. Smaller incisions and the need to reduce trauma require new micro-instrumentation for best outcomes.
New IOL category offers more natural range of visionThere are a number of ways to improve near vision for presbyopes, including multifocal intraocular lenses (IOLs)–traditional or low add–and pseudoaccommodative IOLs. It has been well documented that a small pupil and higher order aberrations, such as spherical aberration (SA) or coma, can increase depth of focus.
DAVE study found little benefit of anti-VEGF/PRP for DMEThe scientific community knows that vascular endothelial growth factor (VEGF) causes increased, vascular permeability, resulting in diabetic macular edema (DME) in the ischemic retina, but how to stop the VEGF drive remains the challenge.
Year-2 Protocol T data paints different scenario from year-1The Diabetic Retinopathy Clinical Research Network’s (DRCR.net) Protocol T—the first head-to-head-to-head comparison among aflibercept (Eylea, Renegeron Pharmaceuticals), ranibizumab (Lucentis, Genentech), and bevacizumab (Avastin, Genentech)—found in its first-year results that all three agents improved vision and reduced edema effectively.
Confocal scanner gives ophthalmologists valuable new tool
12-month results with small-aperture IOL providing patients with an extended range of vision
New technology takes invisibility cloak off in retinal imagingNew imaging technologies, such as ultra-wide-field fluorescein angiography and optical coherence tomography angiography, are providing more details about retinal diseases than previous imaging technologies, leading to better understanding of disease processes.

Poll

View Results